Global In-Vitro Toxicity Testing Market Research Report 2023

Report ID: 2009672 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global In-Vitro Toxicity Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Cell Culture Technologies
        1.2.3 High-throughput Technologies
        1.2.4 Toxicogenomics
    1.3 Market by Application
        1.3.1 Global In-Vitro Toxicity Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Pharmaceuticals & Biopharmaceuticals
        1.3.3 Cosmetic & Household Products
        1.3.4 Food
        1.3.5 Chemicals
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global In-Vitro Toxicity Testing Market Perspective (2017-2028)
    2.2 In-Vitro Toxicity Testing Growth Trends by Region
        2.2.1 In-Vitro Toxicity Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 In-Vitro Toxicity Testing Historic Market Size by Region (2017-2022)
        2.2.3 In-Vitro Toxicity Testing Forecasted Market Size by Region (2023-2028)
    2.3 In-Vitro Toxicity Testing Market Dynamics
        2.3.1 In-Vitro Toxicity Testing Industry Trends
        2.3.2 In-Vitro Toxicity Testing Market Drivers
        2.3.3 In-Vitro Toxicity Testing Market Challenges
        2.3.4 In-Vitro Toxicity Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top In-Vitro Toxicity Testing Players by Revenue
        3.1.1 Global Top In-Vitro Toxicity Testing Players by Revenue (2017-2022)
        3.1.2 Global In-Vitro Toxicity Testing Revenue Market Share by Players (2017-2022)
    3.2 Global In-Vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by In-Vitro Toxicity Testing Revenue
    3.4 Global In-Vitro Toxicity Testing Market Concentration Ratio
        3.4.1 Global In-Vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicity Testing Revenue in 2021
    3.5 In-Vitro Toxicity Testing Key Players Head office and Area Served
    3.6 Key Players In-Vitro Toxicity Testing Product Solution and Service
    3.7 Date of Enter into In-Vitro Toxicity Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Toxicity Testing Breakdown Data by Type
    4.1 Global In-Vitro Toxicity Testing Historic Market Size by Type (2017-2022)
    4.2 Global In-Vitro Toxicity Testing Forecasted Market Size by Type (2023-2028)
5 In-Vitro Toxicity Testing Breakdown Data by Application
    5.1 Global In-Vitro Toxicity Testing Historic Market Size by Application (2017-2022)
    5.2 Global In-Vitro Toxicity Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America In-Vitro Toxicity Testing Market Size (2017-2028)
    6.2 North America In-Vitro Toxicity Testing Market Size by Country (2017-2022)
    6.3 North America In-Vitro Toxicity Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe In-Vitro Toxicity Testing Market Size (2017-2028)
    7.2 Europe In-Vitro Toxicity Testing Market Size by Country (2017-2022)
    7.3 Europe In-Vitro Toxicity Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific In-Vitro Toxicity Testing Market Size (2017-2028)
    8.2 Asia-Pacific In-Vitro Toxicity Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific In-Vitro Toxicity Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America In-Vitro Toxicity Testing Market Size (2017-2028)
    9.2 Latin America In-Vitro Toxicity Testing Market Size by Country (2017-2022)
    9.3 Latin America In-Vitro Toxicity Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa In-Vitro Toxicity Testing Market Size (2017-2028)
    10.2 Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Detail
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific In-Vitro Toxicity Testing Introduction
        11.1.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 Covance
        11.2.1 Covance Company Detail
        11.2.2 Covance Business Overview
        11.2.3 Covance In-Vitro Toxicity Testing Introduction
        11.2.4 Covance Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.2.5 Covance Recent Development
    11.3 Bio-Rad Laboratories
        11.3.1 Bio-Rad Laboratories Company Detail
        11.3.2 Bio-Rad Laboratories Business Overview
        11.3.3 Bio-Rad Laboratories In-Vitro Toxicity Testing Introduction
        11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.3.5 Bio-Rad Laboratories Recent Development
    11.4 GE Healthcare
        11.4.1 GE Healthcare Company Detail
        11.4.2 GE Healthcare Business Overview
        11.4.3 GE Healthcare In-Vitro Toxicity Testing Introduction
        11.4.4 GE Healthcare Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.4.5 GE Healthcare Recent Development
    11.5 Eurofins Scientific
        11.5.1 Eurofins Scientific Company Detail
        11.5.2 Eurofins Scientific Business Overview
        11.5.3 Eurofins Scientific In-Vitro Toxicity Testing Introduction
        11.5.4 Eurofins Scientific Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.5.5 Eurofins Scientific Recent Development
    11.6 Merck KGaA
        11.6.1 Merck KGaA Company Detail
        11.6.2 Merck KGaA Business Overview
        11.6.3 Merck KGaA In-Vitro Toxicity Testing Introduction
        11.6.4 Merck KGaA Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.6.5 Merck KGaA Recent Development
    11.7 Charles River Laboratories
        11.7.1 Charles River Laboratories Company Detail
        11.7.2 Charles River Laboratories Business Overview
        11.7.3 Charles River Laboratories In-Vitro Toxicity Testing Introduction
        11.7.4 Charles River Laboratories Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.7.5 Charles River Laboratories Recent Development
    11.8 Catalent
        11.8.1 Catalent Company Detail
        11.8.2 Catalent Business Overview
        11.8.3 Catalent In-Vitro Toxicity Testing Introduction
        11.8.4 Catalent Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.8.5 Catalent Recent Development
    11.9 Cyprotex
        11.9.1 Cyprotex Company Detail
        11.9.2 Cyprotex Business Overview
        11.9.3 Cyprotex In-Vitro Toxicity Testing Introduction
        11.9.4 Cyprotex Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.9.5 Cyprotex Recent Development
    11.10 QIAGEN
        11.10.1 QIAGEN Company Detail
        11.10.2 QIAGEN Business Overview
        11.10.3 QIAGEN In-Vitro Toxicity Testing Introduction
        11.10.4 QIAGEN Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.10.5 QIAGEN Recent Development
    11.11 Promega
        11.11.1 Promega Company Detail
        11.11.2 Promega Business Overview
        11.11.3 Promega In-Vitro Toxicity Testing Introduction
        11.11.4 Promega Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.11.5 Promega Recent Development
    11.12 Gentronix
        11.12.1 Gentronix Company Detail
        11.12.2 Gentronix Business Overview
        11.12.3 Gentronix In-Vitro Toxicity Testing Introduction
        11.12.4 Gentronix Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.12.5 Gentronix Recent Development
    11.13 BioIVT
        11.13.1 BioIVT Company Detail
        11.13.2 BioIVT Business Overview
        11.13.3 BioIVT In-Vitro Toxicity Testing Introduction
        11.13.4 BioIVT Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.13.5 BioIVT Recent Development
    11.14 MB Research Laboratories
        11.14.1 MB Research Laboratories Company Detail
        11.14.2 MB Research Laboratories Business Overview
        11.14.3 MB Research Laboratories In-Vitro Toxicity Testing Introduction
        11.14.4 MB Research Laboratories Revenue in In-Vitro Toxicity Testing Business (2017-2022)
        11.14.5 MB Research Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global In-Vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Cell Culture Technologies
    Table 3. Key Players of High-throughput Technologies
    Table 4. Key Players of Toxicogenomics
    Table 5. Global In-Vitro Toxicity Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global In-Vitro Toxicity Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global In-Vitro Toxicity Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global In-Vitro Toxicity Testing Market Share by Region (2017-2022)
    Table 9. Global In-Vitro Toxicity Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global In-Vitro Toxicity Testing Market Share by Region (2023-2028)
    Table 11. In-Vitro Toxicity Testing Market Trends
    Table 12. In-Vitro Toxicity Testing Market Drivers
    Table 13. In-Vitro Toxicity Testing Market Challenges
    Table 14. In-Vitro Toxicity Testing Market Restraints
    Table 15. Global In-Vitro Toxicity Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global In-Vitro Toxicity Testing Market Share by Players (2017-2022)
    Table 17. Global Top In-Vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicity Testing as of 2021)
    Table 18. Ranking of Global Top In-Vitro Toxicity Testing Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by In-Vitro Toxicity Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players In-Vitro Toxicity Testing Product Solution and Service
    Table 22. Date of Enter into In-Vitro Toxicity Testing Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global In-Vitro Toxicity Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global In-Vitro Toxicity Testing Revenue Market Share by Type (2017-2022)
    Table 26. Global In-Vitro Toxicity Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global In-Vitro Toxicity Testing Revenue Market Share by Type (2023-2028)
    Table 28. Global In-Vitro Toxicity Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global In-Vitro Toxicity Testing Revenue Market Share by Application (2017-2022)
    Table 30. Global In-Vitro Toxicity Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global In-Vitro Toxicity Testing Revenue Market Share by Application (2023-2028)
    Table 32. North America In-Vitro Toxicity Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America In-Vitro Toxicity Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe In-Vitro Toxicity Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe In-Vitro Toxicity Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific In-Vitro Toxicity Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific In-Vitro Toxicity Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America In-Vitro Toxicity Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America In-Vitro Toxicity Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Thermo Fisher Scientific Company Detail
    Table 43. Thermo Fisher Scientific Business Overview
    Table 44. Thermo Fisher Scientific In-Vitro Toxicity Testing Product
    Table 45. Thermo Fisher Scientific Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 46. Thermo Fisher Scientific Recent Development
    Table 47. Covance Company Detail
    Table 48. Covance Business Overview
    Table 49. Covance In-Vitro Toxicity Testing Product
    Table 50. Covance Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 51. Covance Recent Development
    Table 52. Bio-Rad Laboratories Company Detail
    Table 53. Bio-Rad Laboratories Business Overview
    Table 54. Bio-Rad Laboratories In-Vitro Toxicity Testing Product
    Table 55. Bio-Rad Laboratories Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 56. Bio-Rad Laboratories Recent Development
    Table 57. GE Healthcare Company Detail
    Table 58. GE Healthcare Business Overview
    Table 59. GE Healthcare In-Vitro Toxicity Testing Product
    Table 60. GE Healthcare Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 61. GE Healthcare Recent Development
    Table 62. Eurofins Scientific Company Detail
    Table 63. Eurofins Scientific Business Overview
    Table 64. Eurofins Scientific In-Vitro Toxicity Testing Product
    Table 65. Eurofins Scientific Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 66. Eurofins Scientific Recent Development
    Table 67. Merck KGaA Company Detail
    Table 68. Merck KGaA Business Overview
    Table 69. Merck KGaA In-Vitro Toxicity Testing Product
    Table 70. Merck KGaA Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 71. Merck KGaA Recent Development
    Table 72. Charles River Laboratories Company Detail
    Table 73. Charles River Laboratories Business Overview
    Table 74. Charles River Laboratories In-Vitro Toxicity Testing Product
    Table 75. Charles River Laboratories Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 76. Charles River Laboratories Recent Development
    Table 77. Catalent Company Detail
    Table 78. Catalent Business Overview
    Table 79. Catalent In-Vitro Toxicity Testing Product
    Table 80. Catalent Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 81. Catalent Recent Development
    Table 82. Cyprotex Company Detail
    Table 83. Cyprotex Business Overview
    Table 84. Cyprotex In-Vitro Toxicity Testing Product
    Table 85. Cyprotex Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 86. Cyprotex Recent Development
    Table 87. QIAGEN Company Detail
    Table 88. QIAGEN Business Overview
    Table 89. QIAGEN In-Vitro Toxicity Testing Product
    Table 90. QIAGEN Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 91. QIAGEN Recent Development
    Table 92. Promega Company Detail
    Table 93. Promega Business Overview
    Table 94. Promega In-Vitro Toxicity TestingProduct
    Table 95. Promega Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 96. Promega Recent Development
    Table 97. Gentronix Company Detail
    Table 98. Gentronix Business Overview
    Table 99. Gentronix In-Vitro Toxicity TestingProduct
    Table 100. Gentronix Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 101. Gentronix Recent Development
    Table 102. BioIVT Company Detail
    Table 103. BioIVT Business Overview
    Table 104. BioIVT In-Vitro Toxicity TestingProduct
    Table 105. BioIVT Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 106. BioIVT Recent Development
    Table 107. MB Research Laboratories Company Detail
    Table 108. MB Research Laboratories Business Overview
    Table 109. MB Research Laboratories In-Vitro Toxicity TestingProduct
    Table 110. MB Research Laboratories Revenue in In-Vitro Toxicity Testing Business (2017-2022) & (US$ Million)
    Table 111. MB Research Laboratories Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global In-Vitro Toxicity Testing Market Share by Type: 2021 VS 2028
    Figure 2. Cell Culture Technologies Features
    Figure 3. High-throughput Technologies Features
    Figure 4. Toxicogenomics Features
    Figure 5. Global In-Vitro Toxicity Testing Market Share by Application in 2021 & 2028
    Figure 6. Pharmaceuticals & Biopharmaceuticals Case Studies
    Figure 7. Cosmetic & Household Products Case Studies
    Figure 8. Food Case Studies
    Figure 9. Chemicals Case Studies
    Figure 10. In-Vitro Toxicity Testing Report Years Considered
    Figure 11. Global In-Vitro Toxicity Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global In-Vitro Toxicity Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global In-Vitro Toxicity Testing Market Share by Region: 2021 VS 2028
    Figure 14. Global In-Vitro Toxicity Testing Market Share by Players in 2021
    Figure 15. Global Top In-Vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicity Testing as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by In-Vitro Toxicity Testing Revenue in 2021
    Figure 17. North America In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America In-Vitro Toxicity Testing Market Share by Country (2017-2028)
    Figure 19. United States In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe In-Vitro Toxicity Testing Market Share by Country (2017-2028)
    Figure 23. Germany In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific In-Vitro Toxicity Testing Market Share by Region (2017-2028)
    Figure 31. China In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America In-Vitro Toxicity Testing Market Share by Country (2017-2028)
    Figure 39. Mexico In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa In-Vitro Toxicity Testing Market Share by Country (2017-2028)
    Figure 43. Turkey In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia In-Vitro Toxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 46. Covance Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 47. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 48. GE Healthcare Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 49. Eurofins Scientific Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 50. Merck KGaA Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 51. Charles River Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 52. Catalent Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 53. Cyprotex Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 54. QIAGEN Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 55. Promega Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 56. Gentronix Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 57. BioIVT Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 58. MB Research Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific
Covance
Bio-Rad Laboratories
GE Healthcare
Eurofins Scientific
Merck KGaA
Charles River Laboratories
Catalent
Cyprotex
QIAGEN
Promega
Gentronix
BioIVT
MB Research Laboratories
Frequently Asked Questions
In-Vitro Toxicity Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
In-Vitro Toxicity Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
In-Vitro Toxicity Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Medical Writing

Medical Writing market is segmented by players, region (country), by Type and by Application. Pla ... Read More